News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
156,345 Results
Type
Article (7540)
Company Profile (25)
Press Release (148778)
Multimedia
Podcasts (5)
Webinars (4)
Section
Business (53605)
Career Advice (356)
Deals (9472)
Drug Delivery (8)
Drug Development (19934)
Employer Resources (18)
FDA (3733)
Job Trends (3909)
News (85080)
Policy (6560)
Tag
Academia (498)
Accelerated approval (6)
Adcomms (5)
Allergies (43)
Alliances (7416)
ALS (45)
Alzheimer's disease (360)
Antibody-drug conjugate (ADC) (74)
Approvals (3909)
Artificial intelligence (77)
Autoimmune disease (28)
Automation (3)
Bankruptcy (55)
Best Places to Work (3331)
BIOSECURE Act (4)
Biosimilars (56)
Biotechnology (17)
Bladder cancer (56)
Brain cancer (17)
Breast cancer (196)
Cancer (1331)
Cardiovascular disease (121)
Career advice (330)
Career pathing (5)
CAR-T (45)
CDC (22)
Cell therapy (124)
Cervical cancer (14)
Clinical research (18086)
Collaboration (244)
Company closure (1)
Compensation (182)
Complete response letters (10)
COVID-19 (642)
CRISPR (13)
C-suite (96)
Cystic fibrosis (27)
Data (2014)
Depression (34)
Diabetes (151)
Diagnostics (1432)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (28)
Drug pricing (29)
Drug shortages (1)
Duchenne muscular dystrophy (72)
Earnings (40437)
Editorial (12)
Employer branding (2)
Employer resources (15)
Events (22076)
Executive appointments (98)
FDA (4677)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (9)
Funding (208)
Gene editing (31)
Generative AI (5)
Gene therapy (119)
GLP-1 (289)
Government (929)
Grass and pollen (3)
Guidances (320)
Healthcare (4294)
HIV (18)
Huntington's disease (6)
IgA nephropathy (27)
Immunology and inflammation (75)
Immuno-oncology (11)
Indications (35)
Infectious disease (721)
Inflammatory bowel disease (46)
Inflation Reduction Act (2)
Influenza (24)
Intellectual property (44)
Interviews (48)
IPO (5877)
IRA (4)
Job creations (746)
Job search strategy (315)
Kidney cancer (4)
Labor market (25)
Layoffs (142)
Legal (1212)
Liver cancer (18)
Longevity (3)
Lung cancer (203)
Lymphoma (125)
Machine learning (3)
Management (7)
Manufacturing (104)
MASH (53)
Medical device (3217)
Medtech (3228)
Mergers & acquisitions (3854)
Metabolic disorders (348)
Multiple sclerosis (52)
NASH (5)
Neurodegenerative disease (61)
Neuropsychiatric disorders (23)
Neuroscience (628)
NextGen: Class of 2025 (1355)
Non-profit (916)
Now hiring (7)
Obesity (140)
Opinion (28)
Ovarian cancer (53)
Pain (40)
Pancreatic cancer (50)
Parkinson's disease (59)
Partnered (5)
Patents (84)
Patient recruitment (67)
Peanut (24)
People (7253)
Pharmaceutical (9)
Pharmacy benefit managers (5)
Phase I (4586)
Phase II (7640)
Phase III (7259)
Pipeline (2004)
Policy (39)
Postmarket research (787)
Preclinical (1628)
Press Release (9)
Prostate cancer (77)
Psychedelics (7)
Radiopharmaceuticals (103)
Rare diseases (161)
Real estate (976)
Recruiting (5)
Regulatory (5434)
Reports (18)
Research institute (455)
Resumes & cover letters (41)
Rett syndrome (8)
RNA editing (5)
RSV (36)
Schizophrenia (37)
Series A (28)
Series B (25)
Service/supplier (1)
Sickle cell disease (21)
Special edition (14)
Spinal muscular atrophy (44)
Sponsored (8)
Startups (493)
Stomach cancer (4)
Supply chain (12)
Tariffs (16)
The Weekly (5)
Vaccines (281)
Venture capital (14)
Weight loss (94)
Women's health (15)
Worklife (1)
Date
Today (65)
Last 7 days (178)
Last 30 days (566)
Last 365 days (8797)
2025 (8703)
2024 (9454)
2023 (10669)
2022 (12589)
2021 (13394)
2020 (12173)
2019 (10318)
2018 (7684)
2017 (10866)
2016 (5959)
2015 (7919)
2014 (5565)
2013 (3712)
2012 (4117)
2011 (4301)
2010 (4210)
Location
Africa (274)
Alabama (11)
Alaska (1)
Arizona (37)
Arkansas (2)
Asia (9490)
Australia (1411)
California (2724)
Canada (925)
China (304)
Colorado (149)
Connecticut (132)
Delaware (117)
Europe (24359)
Florida (341)
Georgia (110)
Idaho (9)
Illinois (185)
India (16)
Indiana (158)
Iowa (5)
Japan (128)
Kansas (38)
Kentucky (4)
Louisiana (10)
Maine (32)
Maryland (291)
Massachusetts (1964)
Michigan (80)
Minnesota (157)
Mississippi (4)
Missouri (29)
Montana (6)
Nebraska (2)
Nevada (44)
New Hampshire (19)
New Jersey (972)
New Mexico (1)
New York (839)
North Carolina (407)
North Dakota (1)
Northern California (1369)
Ohio (44)
Oklahoma (1)
Oregon (3)
Pennsylvania (604)
Puerto Rico (4)
Rhode Island (1)
South America (366)
South Carolina (8)
Southern California (1089)
Tennessee (29)
Texas (370)
United States (9990)
Utah (73)
Virginia (50)
Washington D.C. (11)
Washington State (227)
Wisconsin (25)
156,345 Results for "17".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis
December 18, 2025
·
3 min read
Press Releases
Bendit Announces FDA Clearance for the Bendit17™ Steerable Microcatheter
December 10, 2025
·
2 min read
Autoimmune disease
Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
Sanofi bought Dren’s DR-0201 program earlier this year for $600 million upfront and is running two Phase I trials in undisclosed inflammatory indications.
December 15, 2025
·
1 min read
·
Annalee Armstrong
Immunology and inflammation
Novartis Unites With Relation in $1.7B Inflammatory Skin Disease Pact
At the heart of the deal is Relation’s Lab-in-the-Loop platform, which uses AI models to improve understanding of diseases and guide clinical development programs.
December 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Veru to Report Fiscal Year 2025 Financial Results on December 17th
December 11, 2025
·
10 min read
Press Releases
Crescent Biopharma Announces Grants of Inducement Awards - November 17, 2025
November 18, 2025
·
1 min read
Press Releases
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - December 17, 2025
December 18, 2025
·
1 min read
Press Releases
Sensient Announces Conference Call - October 17, 2025
October 20, 2025
·
1 min read
Press Releases
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 16, 2025
·
5 min read
Press Releases
Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis
December 8, 2025
·
5 min read
1 of 15,635
Next
